Tocqueville Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-10,625
| Closed | -$384K | – | 845 |
|
|
2017
Q1 | $384K | Sell |
10,625
-950
| -8% | -$34.3K | ﹤0.01% | 627 |
|
|
2016
Q4 | $580K | Sell |
11,575
-13,000
| -53% | -$651K | 0.01% | 573 |
|
|
2016
Q3 | $1.29M | Sell |
24,575
-20,600
| -46% | -$1.08M | 0.02% | 476 |
|
|
2016
Q2 | $1.87M | Sell |
45,175
-1,000
| -2% | -$41.4K | 0.02% | 422 |
|
|
2016
Q1 | $1.88M | Buy |
46,175
+500
| +1% | +$20.3K | 0.02% | 408 |
|
|
2015
Q4 | $1.9M | Buy |
45,675
+7,500
| +20% | +$311K | 0.03% | 434 |
|
|
2015
Q3 | $588K | Buy |
38,175
+500
| +1% | +$7.7K | 0.01% | 662 |
|
|
2015
Q2 | $936K | Buy |
37,675
+11,675
| +45% | +$290K | 0.01% | 582 |
|
|
2015
Q1 | $594K | Buy |
26,000
+12,775
| +97% | +$292K | 0.01% | 681 |
|
|
2014
Q4 | $357K | Buy |
13,225
+2,000
| +18% | +$54K | ﹤0.01% | 774 |
|
|
2014
Q3 | $132K | Sell |
11,225
-26,800
| -70% | -$315K | ﹤0.01% | 842 |
|
|
2014
Q2 | $591K | Sell |
38,025
-2,000
| -5% | -$31.1K | 0.01% | 682 |
|
|
2014
Q1 | $787K | Buy |
+40,025
| New | +$787K | 0.01% | 493 |
|